144 related articles for article (PubMed ID: 28074906)
1. Antiproliferative Effects of 1α-OH-vitD
Spath L; Ulivieri A; Lavra L; Fidanza L; Carlesimo M; Giubettini M; Narcisi A; Luciani E; Bucci B; Pisani D; Sciacchitano S; Bartolazzi A
Sci Rep; 2017 Jan; 7():40370. PubMed ID: 28074906
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
[TBL] [Abstract][Full Text] [Related]
3. [Effect of vitamin D 2 and 25-hydroxycholecalciferol on intestinal absorption of radiophosphate in man].
Gennari C; Vattimo A; Nardi P
Boll Soc Ital Biol Sper; 1975 Feb; 51(3):86-9. PubMed ID: 1080052
[No Abstract] [Full Text] [Related]
4. [Biological activity of 1alpha-hydroxycholecalciferol (1). Effect on intestine and bone in rats (author's transl)].
Kawashima H; Hoshina K; Saitoh N; Okamiya Y; Hashimoto Y; Ishimoto S; Noguchi T; Orimo H
Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):267-83. PubMed ID: 658840
[TBL] [Abstract][Full Text] [Related]
5. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.
Reade TM; Scriver CR; Glorieux FH; Nogrady B; Delvin E; Poirier R; Holick F; DeLuca HF
Pediatr Res; 1975 Jul; 9(7):593-9. PubMed ID: 1161348
[TBL] [Abstract][Full Text] [Related]
6. Alopecia in vitamin D-dependent rickets type II responding to 1α-hydroxycholecalciferol.
Kumar V; Kumar M; Yadav M
Ann Trop Paediatr; 2010; 30(4):329-33. PubMed ID: 21118628
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
Hussain-Hakimjee EA; Peng X; Mehta RR; Mehta RG
Carcinogenesis; 2006 Mar; 27(3):551-9. PubMed ID: 16195238
[TBL] [Abstract][Full Text] [Related]
8. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
9. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
10. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
Fischer AP; Miles SL
Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the biological activity and toxic effect of 1alpha-hydroxycholecalciferol and ergocalciferol in rats].
Spirichev VB; Blazheevich NV; Bogoslovskiĭ NA; Samokhvalov GI; Avakumov VM
Vopr Med Khim; 1978; 24(5):679-90. PubMed ID: 309216
[TBL] [Abstract][Full Text] [Related]
15. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.
Murillo G; Mehta RG
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D₃ enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression.
Lee JH; Park S; Cheon S; Lee JH; Kim S; Hur DY; Kim TS; Yoon SR; Yang Y; Bang SI; Park H; Lee HT; Cho D
Eur J Immunol; 2011 Oct; 41(10):2937-46. PubMed ID: 21792879
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
19. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
[TBL] [Abstract][Full Text] [Related]
20. [Behavior of serum 25-hydroxycholecalciferol in humans after administration of vitamin D and 25-OHD3].
Coen G; Taccone Gallucci M; Bianchini G; Lucentini G; Gallucci G; Bianchi AR; Matteucci MC; Picca S; Casciani CU
Boll Soc Ital Biol Sper; 1979 Oct; 55(20):2051-6. PubMed ID: 232847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
